Insulet Price to Free Cash Flow Ratio 2010-2025 | PODD
Historical price to free cash flow ratio values for Insulet (PODD) since 2010.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Insulet Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-07-08 | 296.51 | 75.26 | |
| 2025-03-31 | 262.61 | $3.94 | 66.65 |
| 2024-12-31 | 261.07 | $4.13 | 63.16 |
| 2024-09-30 | 232.75 | $3.07 | 75.74 |
| 2024-06-30 | 201.80 | $2.58 | 78.18 |
| 2024-03-31 | 171.40 | $1.98 | 86.44 |
| 2023-12-31 | 216.98 | $0.95 | 227.92 |
| 2023-09-30 | 159.49 | $0.54 | 295.79 |
| 2023-06-30 | 288.34 | $0.43 | 666.07 |
| 2023-03-31 | 318.96 | $0.18 | 1764.16 |
| 2022-12-31 | 294.39 | $-0.06 | 0.00 |
| 2022-09-30 | 229.40 | $-0.72 | 0.00 |
| 2022-06-30 | 217.94 | $-1.81 | 0.00 |
| 2022-03-31 | 266.39 | $-1.98 | 0.00 |
| 2021-12-31 | 266.07 | $-2.62 | 0.00 |
| 2021-09-30 | 284.23 | $-2.28 | 0.00 |
| 2021-06-30 | 274.51 | $-1.29 | 0.00 |
| 2021-03-31 | 260.92 | $-1.23 | 0.00 |
| 2020-12-31 | 255.63 | $-0.68 | 0.00 |
| 2020-09-30 | 236.59 | $-0.20 | 0.00 |
| 2020-06-30 | 194.26 | $-0.33 | 0.00 |
| 2020-03-31 | 165.68 | $-0.91 | 0.00 |
| 2019-12-31 | 171.20 | $-1.05 | 0.00 |
| 2019-09-30 | 164.93 | $-1.05 | 0.00 |
| 2019-06-30 | 119.38 | $-1.49 | 0.00 |
| 2019-03-31 | 95.09 | $-1.93 | 0.00 |
| 2018-12-31 | 79.32 | $-1.99 | 0.00 |
| 2018-09-30 | 105.95 | $-2.02 | 0.00 |
| 2018-06-30 | 85.70 | $-1.49 | 0.00 |
| 2018-03-31 | 86.68 | $-0.41 | 0.00 |
| 2017-12-31 | 69.00 | $-0.56 | 0.00 |
| 2017-09-30 | 55.08 | $-0.19 | 0.00 |
| 2017-06-30 | 51.31 | $-0.63 | 0.00 |
| 2017-03-31 | 43.09 | $-0.69 | 0.00 |
| 2016-12-31 | 37.68 | $-0.11 | 0.00 |
| 2016-09-30 | 40.94 | $-0.80 | 0.00 |
| 2016-06-30 | 30.24 | $-0.50 | 0.00 |
| 2016-03-31 | 33.16 | $-0.51 | 0.00 |
| 2015-12-31 | 37.81 | $-0.41 | 0.00 |
| 2015-09-30 | 25.91 | $0.02 | 1599.38 |
| 2015-06-30 | 30.99 | $-0.06 | 0.00 |
| 2015-03-31 | 33.35 | $-0.13 | 0.00 |
| 2014-12-31 | 46.06 | $-0.05 | 0.00 |
| 2014-09-30 | 36.85 | $-0.20 | 0.00 |
| 2014-06-30 | 39.67 | $-0.20 | 0.00 |
| 2014-03-31 | 47.42 | $-0.09 | 0.00 |
| 2013-12-31 | 37.10 | $-0.07 | 0.00 |
| 2013-09-30 | 36.24 | $-0.12 | 0.00 |
| 2013-06-30 | 31.41 | $-0.32 | 0.00 |
| 2013-03-31 | 25.86 | $-0.66 | 0.00 |
| 2012-12-31 | 21.22 | $-0.84 | 0.00 |
| 2012-09-30 | 21.58 | $-0.90 | 0.00 |
| 2012-06-30 | 21.37 | $-0.81 | 0.00 |
| 2012-03-31 | 19.14 | $-0.77 | 0.00 |
| 2011-12-31 | 18.83 | $-0.78 | 0.00 |
| 2011-09-30 | 15.26 | $-0.84 | 0.00 |
| 2011-06-30 | 22.17 | $-1.10 | 0.00 |
| 2011-03-31 | 20.62 | $-1.03 | 0.00 |
| 2010-12-31 | 15.50 | $-1.06 | 0.00 |
| 2010-09-30 | 14.14 | $-1.07 | 0.00 |
| 2010-06-30 | 15.05 | $-1.16 | 0.00 |
| 2010-03-31 | 15.09 | $-1.56 | 0.00 |
| 2009-12-31 | 14.28 | $-1.76 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $21.162B | $2.072B |
| Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.616B | 27.97 |
| Boston Scientific (BSX) | United States | $153.611B | 38.46 |
| Stryker (SYK) | United States | $149.817B | 31.33 |
| EssilorLuxottica (ESLOY) | France | $128.259B | 0.00 |
| Medtronic (MDT) | Ireland | $112.441B | 15.94 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.320B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.596B | 26.03 |
| ResMed (RMD) | United States | $37.597B | 28.24 |
| GE HealthCare Technologies (GEHC) | United States | $34.163B | 16.22 |
| Agilent Technologies (A) | United States | $33.875B | 22.08 |
| Terumo (TRUMY) | Japan | $24.770B | 32.17 |
| Koninklijke Philips (PHG) | Netherlands | $22.956B | 16.11 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.315B | 11.76 |
| Baxter (BAX) | United States | $15.236B | 11.38 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.113B | 0.00 |
| Demant (WILYY) | Denmark | $8.971B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.723B | 23.40 |
| Lantheus Holdings (LNTH) | United States | $5.479B | 13.82 |
| Prestige Consumer Healthcare (PBH) | United States | $3.900B | 17.42 |
| Perrigo (PRGO) | Ireland | $3.676B | 9.32 |
| Haemonetics (HAE) | United States | $3.609B | 16.44 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.334B | 27.70 |
| ICU Medical (ICUI) | United States | $3.192B | 23.54 |
| QuidelOrtho (QDEL) | United States | $1.976B | 13.59 |
| LeMaitre Vascular (LMAT) | United States | $1.875B | 41.91 |
| AtriCure (ATRC) | United States | $1.561B | 0.00 |
| Acuren (TIC) | United States | $1.375B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.248B | 12.67 |
| Phibro Animal Health (PAHC) | United States | $1.212B | 15.49 |
| Green Thumb Industries (GTBIF) | United States | $1.163B | 26.16 |
| Neogen (NEOG) | United States | $1.081B | 13.83 |
| BioLife Solutions (BLFS) | United States | $1.036B | 0.00 |
| InMode (INMD) | Israel | $0.954B | 9.62 |
| Kestra Medical Technologies (KMTS) | United States | $0.757B | 0.00 |
| Owens & Minor (OMI) | United States | $0.669B | 5.55 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.662B | 0.00 |
| CeriBell (CBLL) | United States | $0.622B | 0.00 |
| Evolus (EOLS) | United States | $0.589B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.553B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.507B | 0.00 |
| Valneva SE (VALN) | France | $0.488B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.452B | 0.00 |
| Surmodics (SRDX) | United States | $0.424B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.360B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.344B | 12.67 |
| SNDL (SNDL) | Canada | $0.326B | 0.00 |
| Quanterix (QTRX) | United States | $0.315B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.284B | 0.00 |
| Cerus (CERS) | United States | $0.277B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.272B | 22.90 |
| ZimVie (ZIMV) | United States | $0.263B | 11.94 |
| Sanara MedTech (SMTI) | United States | $0.259B | 0.00 |
| Brainsway (BWAY) | Israel | $0.253B | 66.85 |
| Aurora Cannabis (ACB) | Canada | $0.249B | 73.83 |
| Cresco Labs (CRLBF) | United States | $0.247B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.228B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.221B | 0.00 |
| Biote (BTMD) | United States | $0.218B | 6.14 |
| TriSalus Life Sciences (TLSI) | United States | $0.188B | 0.00 |
| High Tide (HITI) | Canada | $0.188B | 0.00 |
| Organigram Global (OGI) | Canada | $0.186B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 15.13 |
| Omeros (OMER) | United States | $0.180B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.173B | 0.00 |
| Exagen (XGN) | United States | $0.148B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.147B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.129B | 15.90 |
| Apyx Medical (APYX) | United States | $0.098B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 12.37 |
| Jin Medical (ZJYL) | China | $0.090B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.088B | 0.00 |
| MacroGenics (MGNX) | United States | $0.086B | 0.00 |
| Veru (VERU) | United States | $0.086B | 0.00 |
| Zynex (ZYXI) | United States | $0.076B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.075B | 0.00 |
| Agape ATP (ATPC) | $0.070B | 0.00 | |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.064B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.062B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 58.29 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| Safety Shot (SHOT) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.10 |
| Rockwell Medical (RMTI) | United States | $0.027B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |